Express Pharma

JULY 3, 2023

How is the industry’s approach to drug development transforming? How is Waters aiding advancements in drug development? A central aim in drug development is to create new molecular entities into commercially viable drugs useful in managing diseases. What are the imperatives that led to this change?

Biosimilars 95

Biosimilars Drug Development Generic Medicine Diabetes 95

European Pharmaceutical Review

JULY 13, 2023

3 With established drug development pathways, we are accustomed to a rigid structure of translation from bench to bedside. 5 These compounds have been shown in pre-clinical studies to have an array of potential effects on the immune, nervous, cardiovascular, respiratory and endocrine systems.

Compounding 98

Compounding Drug Development Clinical Pharmacology Documentation 98

Safe Biologics

NOVEMBER 12, 2023

The product is an interleukin-6 (IL-6) receptor antagonist that targets specific inflammatory proteins to suppress the immune system. Consider how these perverse incentives could prevent the development of the next Keytruda, the Merck miracle drug perhaps best known for helping former President Jimmy Carter beat cancer.

Biosimilars 130

Biosimilars Drug Pricing Packaging Labelling 130

pharmaphorum

JULY 28, 2021

The collaboration with Google sister company Calico – formed in 2014 with $1.5 The clinical-stage projects include two immuno-oncology candidates in phase 1 testing – both PTPN2 inhibitors – that “act at multiple steps in the cancer immunity cycle”, and a drug for a neurodegenerative disease, according to a February update.

Immunity 59

Immunity Immunization Drug Development 59

pharmaphorum

JUNE 8, 2021

All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. He has been reporting on the pharma industry since 2014 and has worked at a number of leading publications in the UK. Chemotherapy still accounted for 72.6% About the author.

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunity 105

PharmaShots

FEBRUARY 21, 2023

Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. The company is developing PPMX-T002, an anti-cancer drug with an antibody targeting CDH3 connected with a radioisotope yttrium 90 (90Y).

Dosage 56

Dosage Labelling Immunity Immunization 56

PharmaShots

JANUARY 31, 2023

Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Founded Year: 2014 No. Funding Value: $7.7M Founded Year: 2021 No. of Shares: 1.3M Funding Value: $11.5M Founded Year: 2018 No. of Shares: 2.3M

Vaccines 40

Vaccines Immunity Immunization Diabetes 40